The aim of this systematic review was to identify COVID- 19 mortality rate and risk among patients with diabetes. Our review showed that mortality rate due to COVID- 19 varied widely according to each study, however, in all the mortality rate was higher among patients with diabetes. Nevertheless, while evaluating the average mortality risk for patients with diabetes in relation to non-diabetics patients, OR was 8.9 times higher. The new finding that o HB1Ac level and diagnosis time can contribute to higher mortality.
In one of the first published studies evaluating the mortality risk of COVID- 19, the authors showed that older age, high SOFA score and d-dimer greater than 1 μg / mL could help clinicians to identify patients with poor prognosis at an early stage17. Also is known that the age-dependent defects in T-cell and B-cell functioning and the excess production of type 2 cytokines could lead to a deficiency in viral control replication and more prolonged proinflammatory responses, potentially leading to poor outcome18. It is known that the sofa severity scale is also a good marker of mortality in patients with sepsis19; it has been shown that sepsis occurs in about 40% of patients with COVID- 19 due to pneumonia20.
After these findings, other studies began to evaluate other prognostic factors, such as heart disease, arterial hypertension, chronic obstructive lung Ddsease, chronic kidney disease and carcinoma21,22,23. Diabetes and uncontrolled glycaemia were reported as significant predictors of severity and deaths in patients infected with different viruses - including the 2009 pandemic influenza A (H1N1)24 , SARS-CoV25 and MERS-CoV26. Previous studies had shown the risk of complications of COVID- 19 in patients with diabetes, with increased rates in ICU admission ICU and mechanical ventilation need 7,9.
Most recently a meta-analysis showed that diabetic patients with COVID-19 infection have an higher risk of ICU admission and higher mortality risk 27. A relationship between diabetes and infection has long been clinically recognized28. Infections - particularly influenza and pneumonia - are common and more serious in older people with type 2 diabetes mellitus28, However, there is no evidence whether diabetes itself increases susceptibility of infections developing in these patients. Still, remains uncertain how exactly the inflammatory and immune response occurs in patients COVID- 19, as well as whether hyper or hypoglycemia may alter the SARS-CoV-2 virulence or the virus itself interferes with insulin secretion or glycemic control.
There are several hypotheses for which the patient with diabetes has complications due to COVID-19. Chronic inflammation, increased coagulation activity, immune response impairment and potential direct pancreatic damage by SARS-CoV-2 might be among the underlying pathophysiological mechanisms contributing to the increased morbidity and mortality of COVID-19 in people with diabetes 29.
Another possibility is that diabetes is a chronic inflammatory condition characterized by multiple metabolic and vascular abnormalities that can affect it response to pathogens30. Hyperglycemia and insulin resistance promote increased synthesis of the end of glycosylation oxidative stress products (AGEs), and proinflammatory cytokines; in addition, it stimulates the production of adhesion molecules that mediate tissue inflammation14,15. This inflammatory process may be part of the underlying mechanism that leads to a greater propensity to infections - worse results in patients with diabetes31.
Insulin resistance and T2DM are associated with endothelial dysfunction and increased platelet aggregation and activation. These abnormalities predispose the hypercoagulable prothrombotic state development 32. It is possible that coagulation disorders are one of the main mechanisms that increase mortality from COVID- 19 among patients with diabetes. Coronavirus inoculation has already been found in pancreatic islets. Therefore, although more evidence is needed, pancreatic damage may also be present in patients with COVID-19, possibly contributing to a higher risk of mortality in diabetic patients33.
Although diabetes is associated with worse prognosis for COVID- 19 patients, the susceptibility to COVID-19 infection does not appear to be greater than non-diabetic individuals. According to several studies, the prevalence of diabetes in people infected with the virus is about the same as overall population, even slightly lower34.
The limitations of this study are related to the fact that we did not carry out risk analysis corrected by age and sex; as it is already known that age, as well as, male gender can influence higher mortality rates. Nevertheless, this study has important clinical applications related to the fact that the increase in mortality in diabetic patients may be related to coagulation disorders and pancreatic changes.